Dudediligence.

Achieve Life Sciences, Inc

ACHVNASDAQ · In Vitro & in Vivo Diagnostic Substances
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$155,108

1 notice · 20,626 sh

PLANNED · FORM 144REPORTED · FORM 4none, Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-08-19: Stewart Richard Alistair, Form 144
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-08-19Stewart Richard Alistair, Chief Executive Officer$155,108
20,626 shno plan dateForm 4s on file end Jun 23144 ↗